# Switch From Combivir or Trizivir to Truvada - Mitochondrial Effects

> **NCT00960622** · PHASE4 · COMPLETED · sponsor: **St. Luke's-Roosevelt Hospital Center** · enrollment: 17 (actual)

## Conditions studied

- HIV

## Interventions

- **DRUG:** Truvada
- **DRUG:** Combivir
- **DRUG:** Trizivir

## Key facts

- **NCT ID:** NCT00960622
- **Lead sponsor:** St. Luke's-Roosevelt Hospital Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2013-03-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00960622

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00960622, "Switch From Combivir or Trizivir to Truvada - Mitochondrial Effects". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00960622. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*